Viewpoints

Moving Into the Next Phase

May 02, 2021

As face masks start to come off, bio/pharma’s COVID-19 battle goes on.

Acknowledging Bio/Pharma Innovation

May 02, 2021

The world of bio/pharma has been celebrating its achievements across a variety of categories in the latest rounds of awards.

A Watchful Eye on Pharma: Promising Drugs and Changing Bio/Pharma Landscape

April 02, 2021

COVID-19 has placed bio/pharma in the spotlight of global media, but away from vaccines there are other prospective pipeline treatments that will be worth watching.

Fighting Through This Slow Season of Change

March 02, 2021

Bio/pharma works hard today to change the calendar to tomorrow.

Meeting CGT Demand

March 02, 2021

More work is needed to ensure the rising demand for cell and gene therapy manufacturing capacity and required skilled workforce can be met in Europe.

Continued Innovation is Key for COVID-19 Recovery

February 02, 2021

More work is needed to educate businesses on the value of innovation and the availability of funding.

In Short Supply

February 02, 2021

COVID-19 vaccine supplies are breaking news headlines, in both ‘good’ and ‘not so good’ ways.

How Pharmaceutical Innovation is Saving the World

February 02, 2021

Viewpoint

Viewpoint: Mike Hennessy, Sr., founder and chairman of MJH Life Sciences, commends the leadership of the pharmaceutical industry in combatting the COVID-19 pandemic.

A Hopeful but Dangerous Phase

February 02, 2021

A complicated vaccination rollout and mixed messages may derail the pandemic endgame.

A Bright Outlook

January 02, 2021

The outlook for the European pharma industry is appearing to be favourable overall.